Cardiac endogenous transmitter system: molecular features, functions, and clinical implications.

Area of Science:

• Cardiovascular Physiology
• Neurotransmitter Systems
• Cardiac Electrophysiology

Background:

• Traditionally, the heart was considered devoid of endogenous transmitter systems (ETSs).
• Recent research reveals the presence of ETSs within cardiomyocytes and cardiac pacemaker cells.
• Established neurotransmitter systems regulate neuronal signaling but their cardiac roles are newly explored.

Purpose of the Study:

• To review the molecular composition, functions, and implications of endogenous glutamatergic, cholinergic, and GABAergic systems in the heart.
• To analyze the arrhythmogenic potential and therapeutic possibilities of cardiac ETSs.
• To propose a novel transmitter-based model for cardiac bioelectric regulation.

Main Methods:

• Comprehensive literature review of studies on cardiac neurotransmitter systems.
• Analysis of molecular, electrophysiological, and functional data related to cardiac ETSs.
• Synthesis of findings to develop a conceptual model of cardiac bioelectric regulation.

Main Results:

• Identification and characterization of endogenous glutamatergic, cholinergic, and GABAergic systems in cardiac cells.
• Demonstration of the electrophysiological roles of these systems in the heart.
• Evidence linking cardiac ETSs to arrhythmogenesis and potential therapeutic interventions.

Conclusions:

• The heart actively utilizes endogenous transmitter systems for bioelectric regulation.
• Cardiac ETSs represent promising targets for novel anti-arrhythmic therapies.
• A transmitter-based model provides a new framework for understanding cardiac electrophysiology and disease.